- Home
- HCKT vs INO Comparison
HCKT vs INO Comparison
Compare HCKT & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCKT | INO |
|---|---|---|
| Founded | 1991 | 1979 |
| Country | United States | United States |
| Employees | 1478 | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 500.5M | 136.6M |
| IPO Year | 1998 | 1998 |
Fundamental Metrics
Financial Performance| Metric | HCKT | INO |
|---|---|---|
| Price | $19.94 | $2.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $27.00 | $9.00 |
| AVG Volume (30 Days) | 410.4K | ★ 1.4M |
| Earning Date | 11-04-2025 | 11-10-2025 |
| Dividend Yield | ★ 2.41% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | ★ $303,482,000.00 | $182,337.00 |
| Revenue This Year | $0.07 | N/A |
| Revenue Next Year | N/A | $21,219.94 |
| P/E Ratio | $51.95 | ★ N/A |
| Revenue Growth | ★ 0.91 | N/A |
| 52 Week Low | $17.53 | $1.30 |
| 52 Week High | $34.02 | $2.98 |
Technical Indicators
Market Signals| Indicator | HCKT | INO |
|---|---|---|
| Relative Strength Index (RSI) | 58.25 | 54.75 |
| Support Level | $19.83 | $2.26 |
| Resistance Level | $20.68 | $2.72 |
| Average True Range (ATR) | 0.53 | 0.17 |
| MACD | 0.05 | 0.04 |
| Stochastic Oscillator | 62.18 | 45.73 |
Price Performance
Historical ComparisonAbout HCKT Hackett Group Inc (The).
The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.